Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir

Journal of Clinical Microbiology

Volumn 43, Issue 10, 2005, Pages 5003-5008

  Lee, Gyu Cheol ^a,b   Lee, Dong Gun ^a   Choi, Su Mi ^a   Yoo, Jin Hong ^a   Park, Sun Hee ^a   Choi, Jung Hyun ^a   Min, Woo Sung ^a   Cho, Ok Hee ^a   Lee, Chan Hee ^c   Shin, Wan Shik ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea Water Resources Corporation   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; GANCICLOVIR;

ACCURACY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG RESISTANCE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; UL54 GENE; UL97 GENE; VIRUS CULTURE; VIRUS GENE; VIRUS RESISTANCE; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; FLOW CYTOMETRY; GANCICLOVIR; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLAQUE ASSAY; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 26944484403     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.10.5003-5008.2005     Document Type: Article

References (26)

1. Abraham, B., S. Lastere, J. Reynes, F. Bibollet-Ruche, N. Vidal, and M. Segondy. 1999. Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir. J. Clin. Virol. 13:141-148.
2. Alain, S., P. Honderlick, D. Grenet, M. Stern, C. Vadam, M. J. Sanson-Le Pors, and M. C. Mazeron. 1997. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient. Transplantation 63:1533-1536.
3. Baldanti, F., and G. Gerna. 2003. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J. Antimicrob. Chemother. 52:324-330.
4. Baldanti, F., L. Simoncini, A. Sarasini, M. Zavattoni, P. Grossi, M. G. Revello, and G. Gerna. 1998. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation 66:324-329.
5. Baldanti, F., M. R. Underwood, C. L. Talarico, L. Simoncini, A. Sarasini, K. K. Biron, and G. Gerna. 1998. The Cys607→Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients. Antimicrob. Agents Chemother. 42:444-446.
6. Chou, S. 1999. Antiviral drug resistance in human cytomegalovirus. Transl. Infect. Dis. 1:105-114.
7. Chou, S., A. Erice, M. C. Jordan, G. M. Vercellotti, K. R. Michels, C. L. Talarico, S. C. Stanat, and K. K. Biron. 1995. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J. Infect. Dis. 171:576-583.
8. Chou, S., G. Marousek, S. Guentzel, S. E. Follansbee, M. E. Poscher, J. P. Lalezari, R. C. Miner, and W. L. Drew. 1997. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J. Infect. Dis. 176:786-789.
9. Chou, S., and C. L. Meichsner. 2000. A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir. Antimicrob. Agents Chemother. 44:183-185.
10. Cihlar, T., M. D. Fuller, and J. M. Cherrington. 1998. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. J. Virol. 72:5927-5936.
11. De Clercq, E. 2004. Antiviral drugs in current clinical use. J. Clin. Virol. 30:115-133.
12. Drew, W. L., R. Miner, and E. Saleh. 1993. Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clin. Diagn. Virol. 1:179-185.
13. Erice, A. 1999. Resistance of human cytomegalovirus to antiviral drugs. Clin. Microbiol. Rev. 12:286-297.
14. Jabs, D. A., C. Enger, J. P. Dunn, and M. Forman. 1998. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. J. Infect. Dis. 177:770-773.
15. Jabs, D. A., C. Enger, M. Forman, and J. P. Dunn for The Cytomegalovirus Retinitis and Viral Resistance Study Group. 1998. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. Antimicrob. Agents Chemother. 42:2240-2244.
16. Kesson, A. M., F. Zeng, A. L. Cunningham, and W. D. Rawlinson. 1998. The use of flow cytometry to detect antiviral resistance in human cytomegalovirus. J. Virol. Methods 71:177-186.
17. Landry, M. L., S. Stanat, K. Biron, D. Brambilla, W. Britt, J. Jokela, S. Chou, W. L. Drew, A. Erice, B. Gilliam, N. Lurain, J. Manischewitz, R. Miner, M. Nokta, P. Reichelderfer, S. Spector, A. Weinberg, B. Yen-Lieberman, and C. Crumpacker. 2000. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob. Agents Chemother. 44:688-692.
18. Lipson, S. M., M. Soni, F. X. Biondo, D. H. Shepp, M. H. Kaplan, and T. Sun. 1997. Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance. Diagn. Microbiol. Infect. Dis. 28:123-129.
19. McSharry, J. M., N. S. Lurain, G. L. Drusano, A. Landay, M. Nokta, M. O'Gorman, A. Weinberg, H. M. Shapiro, P. Reichelderfer, and C. Crumpacker. 1998. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob. Agents Chemother. 42:2326-2331.
20. McSharry, J. M., N. S. Lurain, G. L. Drusano, A. Landay, J. Manischewitz, M. Nokta, M. O'Gorman, H. M. Shapiro, A. Weinberg, P. Reichelderfer, and C. Crumpacker. 1998. Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates. J. Clin. Microbiol. 36:958-964.
21. Mendez, J. C., I. G. Sia, K. R. Tau, M. J. Espy, T. F. Smith, S. Chou, and C. V. Paya. 1999. Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy. Transplantation 67:755-757.
22. Prix, L., K. Hamprecht, B. Holzhuter, R. Handgretinger, T. Klingebiel, and G. Jahn. 1999. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J. Infect. Dis. 180:491-495.
23. Prix, L., J. Maierl, G. Jahn, and K. Hamprecht. 1998. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J. Clin. Virol. 11:29-37.
24. Smith, I. L., J. M. Cherrington, R. E. Jiles, M. D. Fuller, W. R. Freeman, and S. A. Spector. 1997. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J. Infect. Dis. 176:69-77.
25. Wentworth, B. B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258.
26. Wolf, D. G., I. L. Smith, D. J. Lee, W. R. Freeman, M. Flores-Aguilar, and S. A. Spector. 1995. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J. Clin. Investig. 95:257-263.